Faculty Disclosures
| Shlomo Shinnar, MD, PhD |
No disclosure on file
|
| Tallie Z. Baram, MD, PhD |
No disclosure on file
|
| Dale C. Hesdorffer |
No disclosure on file
|
| Jose E. Cavazos, MD, PhD |
Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH. |
| Richard L. Doty, PhD, FAAN |
Dr. Doty has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sensonics International. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for State of Kansas. Dr. Doty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Johnson & Johnson. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for McMahan Law Firm. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Offices of Walkup et al.. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ostroff Injury Law PC. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sacchett & Baldino. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Nebenzahl Law Group. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ohio National Life Insurance Co. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Tatum and Atkinson LLC. Dr. Doty has stock in Sensonics International. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care. |
| Shigetoshi Takaya, MD, PhD |
No disclosure on file
|
| Andrew Cole, MD, FAAN |
Dr. Cole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Cole has received publishing royalties from a publication relating to health care. |
| Lucie Suchomelova |
No disclosure on file
|
|
No disclosure on file
|
| Ann Marie Collier, MD, FAAN |
Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW BIosciences. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LivaNova. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK lifescience. |
| Shannon Sparrow |
No disclosure on file
|
| Michael R. Sperling, MD, FAAN |
Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium . |
| Claude G. Wasterlain, MD, FAAN |
The institution of Dr. Wasterlain has received research support from Eisai. Dr. Wasterlain has received publishing royalties from a publication relating to health care. |
| Erik Wallstroem, MD, PhD |
Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care. |
| Yasar Zorlu, MD |
No disclosure on file
|
| William Barr |
No disclosure on file
|
| Susan T. Herman, MD, FAAN |
The institution of Dr. Herman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities. |
| Claus Reinsberger, MD |
Dr. Reinsberger has received personal compensation in the range of $0-$499 for serving as a Consultant for the German Football Association. The institution of Dr. Reinsberger has received research support from Federal Institute of Sports Science. The institution of Dr. Reinsberger has received research support from Heinz Nixdorf Westfalian Foundation. The institution of Dr. Reinsberger has received research support from German Research Foundation. |
| Michael F. Waters, MD, PhD, FAAN |
Dr. Waters has nothing to disclose. |
| Orrin Devinsky, MD, FAAN |
Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has received stock or an ownership interest from Engage. Dr. Devinsky has received stock or an ownership interest from Empatica. Dr. Devinsky has received stock or an ownership interest from California Cannabis Enterprises. Dr. Devinsky has received stock or an ownership interest from Empatica. Dr. Devinsky has received stock or an ownership interest from Silver Spike. Dr. Devinsky has received stock or an ownership interest from Docklight Brands. Dr. Devinsky has received stock or an ownership interest from Egg Rock/Papa Barkley. Dr. Devinsky has received stock or an ownership interest from Leafly. Dr. Devinsky has received stock or an ownership interest from Left Coast Ventures. Dr. Devinsky has received stock or an ownership interest from Privateer Holdings. Dr. Devinsky has received stock or an ownership interest from Receptor Holdings. Dr. Devinsky has received stock or an ownership interest from Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care. |
| Alvaro Pascual-Leone, MD, PhD, FAAN |
Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magstim. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Pascual-Leone has stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care. |
| Vishunmurthy S. Hedna, MD |
No disclosure on file
|
| Aunali S. Khaku, MD, MBA |
No disclosure on file
|
| Israel Steiner, MD |
No disclosure on file
|
| John M. Stern, MD, FAAN |
Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. |
| Paul Matthews, MD |
No disclosure on file
|
| Harvey S. Levin, PhD |
No disclosure on file
|
| Steven Jacobson |
Steven Jacobson has nothing to disclose. |
| William H. Theodore, MD, FAAN |
Dr. Theodore has a non-compensated relationship as a Treasurer and vice president with American Epilepsy Society that is relevant to AAN interests or activities. |
| Felix Benninger, MD |
Dr. Benninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurohelp. |
| Zulfi Haneef, MD, MBBS, MRCP, FAAN |
Dr. Haneef has nothing to disclose. |
| Steven C. Schachter, MD, FAAN |
Dr. Schachter has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Schachter has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Schachter has received intellectual property interests from a discovery or technology relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care. |
| Sara Inati, MD |
No disclosure on file
|
| Mouhsin Shafi, MD, PhD |
No disclosure on file
|
| Anli Liu, MD |
Dr. Liu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ECRI. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace Inc. |
| Maja Steinlin, MD |
No disclosure on file
|
| Heidi Munger Clary, MD, MPH |
The institution of Dr. Munger Clary has received research support from National Institute of Health. The institution of Dr. Munger Clary has received research support from Suzanne Marcus Collins Foundation. The institution of Dr. Munger Clary has received research support from Eysz, Inc. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a speaker with American Epilepsy Society. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as a Speaker with J. Kiffin Penry Epilepsy Education Programs. Dr. Munger Clary has a non-compensated relationship as a Chair, Psychosocial Comorbidities Committee with American Epilepsy Society that is relevant to AAN interests or activities. |
| Daniel Press, MD |
The institution of Dr. Press has received research support from NIH. The institution of Dr. Press has received research support from Biogen. The institution of Dr. Press has received research support from Janssen. Dr. Press has received publishing royalties from a publication relating to health care. |
| Daniel Friedman, MD |
The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with AAN. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America. |
| Bridgette J. Billioux, MD |
Dr. Billioux has nothing to disclose. |
| Amrit Misra, MD, PhD |
No disclosure on file
|
| Nicholas Pavlatos |
No disclosure on file
|
| David Rog, MBBS |
Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen-Cilag. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. The institution of Dr. Rog has received research support from Actelion. The institution of Dr. Rog has received research support from Biogen. The institution of Dr. Rog has received research support from MedDay. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Mitsubishi. The institution of Dr. Rog has received research support from Novartis. The institution of an immediate family member of Dr. Rog has received research support from Sanofi Genzyme. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag. |
| Jerome Engel, Jr., MD, PhD, FAAN |
Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebel. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Engel has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Engel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Steven Barris. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cutler Law Firm. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. |
| Steve Chung, MD, FAAN |
The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion. |
| Sharon Chiang, MD, PhD |
Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 . |
| Judy Li, DO |
No disclosure on file
|
| Emily Leibovitch |
No disclosure on file
|
| Jerzy P. Szaflarski, MD, PhD, FAAN |
Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea. |
| Stefano Jann, MD |
No disclosure on file
|
| Xianda Long |
No disclosure on file
|
| Jane B. Allendorfer, PhD |
An immediate family member of Dr. Allendorfer has received personal compensation for serving as an employee of Northport Health Services, LLC. The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities. |
| Douglas K. Sato, MD |
Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck. |
| Johannes Mathis, MD |
No disclosure on file
|
| Suresh Kumar, MD |
Dr. Kumar has nothing to disclose. |
| Maurice M. Ohayon, MD, PhD, DSc |
The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals. |
| Michael Girouard |
No disclosure on file
|
| In Hye Jeong, MD |
No disclosure on file
|